Latest News and Press Releases

JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of...

Dyadic Attends Investor Events in December

Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines Two MoU’s with Fondazione Biotecnopolo di Siena in Italy and Essential Drugs Company Limited...

JUPITER, Fla. and DHAKA, Bangladesh, June 21, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...

Jeddah, Saudi Arabia, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Two women scientists were announced King Faisal Prize for Medicine and Science laureates for 2023: a Covid-19 vaccine developer and a...

NEWPORT BEACH, Calif., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent (PIC) has released an update to its educational document "COVID-19 Vaccine Mandates: 21 Scientific Facts That...

JUPITER, Fla., June 09, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and...

NEWPORT BEACH, Calif., May 01, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent (PIC), an educational nonprofit organization focused on science and statistics, has submitted an opposition...

JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and...

NEWPORT BEACH, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent (PIC), an educational nonprofit organization focused on science and statistics, has submitted an opposition...